fluoromethylcholine (18f)
Trade name: FCH
Small moleculeexperimentalImaging agent
Clinical trial activity
10 trials · 17 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
7
Phase 3
3
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00928252)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
Loading structure…
SMILES
C[N+](C)(C)CCOCF- Mol. weight
- 136.19 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3707346 ↗
- ChEMBLCHEMBL3707345 ↗
Also known as
- [18f]-choline
- 18f choline
- 18f choline
- 18f-choline
- 18f-choline
- 18f-choline
- 18f-fluoromethylcholine
- 18f-fluoromethylcholine
- f18 methylcholine
- fluoromethylcholine
- fluoromethylcholine
- fluoromethylcholine
- fluoromethylcholine
- fluoromethylcholine (18f)
- fluoromethylcholine (18f)
- fluoromethylcholine (18f)
- fluoromethylcholine (18f)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02840552 | Phase 3 | Sep 1, 2016 | McGill University, University of Montreal |
| NCT02640313 | Phase 3 | Dec 1, 2015 | Maastricht University |
| NCT02432599 | Phase 2 | Mar 1, 2015 | University of Caen-Normandie |
| NCT01804231 | N/A | Jul 9, 2013 | Canadian Institutes of Health Research (CIHR), University of Western Ontario |
| NCT01899014 | Phase 3 | Jul 1, 2013 | Maastricht University |
| NCT01395030 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2011 | National Cancer Institute (NCI), National Institutes of Health (NIH), The Queen's Medical Center, University of Hawaii, University of Nottingham |
| NCT01132599 | Phase 2 | May 1, 2010 | Cancer Research UK, University of London |
| NCT00628940 | Phase 1 | Jan 1, 2010 | FWO, Belgium, Ghent University, Special Research Fund, Belgium |
| NCT00928252 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2009 | National Cancer Institute (NCI), National Institutes of Health (NIH), The Queen's Medical Center, University of Nottingham |
| NCT07218224 | N/A | — | University of California, San Francisco |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (17)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Maastricht University | Academic/Hospital | 2 | 2 | 1 | 2013 |
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2009 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 1 | 2009 |
| The Queen's Medical Center | Academic/Hospital | 2 | 0 | 1 | 2009 |
| University of Nottingham | Academic/Hospital | 2 | 2 | 1 | 2009 |
| Canadian Institutes of Health Research (CIHR) | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Cancer Research UK | Academic/Hospital | 1 | 1 | 1 | 2010 |
| FWO, Belgium | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Ghent University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| McGill University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Special Research Fund, Belgium | Government | 1 | 0 | 1 | 2010 |
| University of Caen-Normandie | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | — |
| University of Hawaii | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Montreal | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Western Ontario | Academic/Hospital | 1 | 1 | 1 | 2013 |
17 organizations
Page 1 / 1